Pancreatic cancer metabolism is dramatically rewired by oncogenic KRAS that induces a series of metabolic alterations, which includes enhanced glycolysis and glutaminolysis, resulting in enhanced cell growth and proliferation [7]. Here, KRAS is linked to pancreatic neoplasm.